Epic Sciences Comprehensive Cancer Profiling Platform Shows Compelling Value Of Cell Analysis In Data Presented At ESMO Congress 2021
- Saturday, September 18, 2021, 7:11
- PR Newswire
- Add a comment
SAN DIEGO, Sept. 18, 2021 /PRNewswire/ — Epic Sciences, Inc.’s (Epic) Comprehensive Cancer Profiling™ Platform continues to deliver compelling cell analysis information in clinical trials as data being presented today at the virtual European Society for Medical Oncology Congress 2021…